{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:25:14Z","timestamp":1783697114765,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["BA16\/00037"],"award-info":[{"award-number":["BA16\/00037"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds Yvonne Bo\u00ebl","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The updated 2016 World Health Organization (WHO) classification system for gliomas integrates molecular alterations and histology to provide a greater diagnostic and prognostic utility than the previous, histology-based classification. The increasing number of markers that are tested in a correct diagnostic procedure makes gene-targeted, next-generation sequencing (NGS) a powerful tool in routine pathology practice. We designed a 14-gene NGS panel specifically aimed at the diagnosis of glioma, which allows simultaneous detection of mutations and copy number variations, including the 1p\/19q-codeletion and Epidermal Growth Factor Receptor (EGFR) amplification. To validate this panel, we used reference mutated DNAs, nontumor and non-glioma samples, and 52 glioma samples that were previously characterized. The panel was then prospectively applied to 91 brain lesions. A specificity of 100% and sensitivity of 99.4% was achieved for mutation detection. Orthogonal methods, such as in situ hybridization and immunohistochemical techniques, were used for validation, which showed high concordance. The molecular alterations that were identified allowed diagnosis according to the updated WHO criteria, and helped in the differential diagnosis of difficult cases. This NGS panel is an accurate and sensitive method, which could replace multiple tests for the same sample. Moreover, it is a rapid and cost-effective approach that can be easily implemented in the routine diagnosis of gliomas.<\/jats:p>","DOI":"10.3390\/cancers11060773","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T09:37:58Z","timestamp":1559727478000},"page":"773","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-377X","authenticated-orcid":false,"given":"Nicky","family":"D\u2019Haene","sequence":"first","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-8895","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Mel\u00e9ndez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"De N\u00e8ve","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Lebrun","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Van Campenhout","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Salmon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Network","year":"2008","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrc3655","article-title":"Paediatric and adult glioblastoma: Multiform (epi)genomic culprits emerge","volume":"14","author":"Sturm","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","unstructured":"Louis, D.N., Ohgaki, H., Wiestler, O.D., and Cavenee, W.K. (2016). WHO Classification of Tumours of the Central Nervous System, IARC Press. Revised 4th ed."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00401-017-1690-1","article-title":"Adult infiltrating gliomas with WHO 2016 integrated diagnosis: Additional prognostic roles of ATRX and TERT","volume":"133","author":"Pekmezci","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Lachance","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/his.12927","article-title":"Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas","volume":"69","author":"Ikemura","year":"2016","journal-title":"Histopathology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/NEN.0000000000000167","article-title":"Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade","volume":"74","author":"Mur","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20885","DOI":"10.18632\/oncotarget.4928","article-title":"Combination genetic signature stratifies lower-grade gliomas better than histological grade","volume":"6","author":"Chan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","article-title":"Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: Long-term results of RTOG 9402","volume":"31","author":"Cairncross","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J. Natl. Cancer. Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5414\/NPP30047","article-title":"FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: Procedures and protocols for neuropathological practice\u2014A publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS)","volume":"30","author":"Woehrer","year":"2011","journal-title":"Clin. Neuropathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/NEN.0b013e318240fa65","article-title":"The importance of 10q status in an outcomes-based comparison between 1p\/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas","volume":"71","author":"Horbinski","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bpa.12367","article-title":"Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel","volume":"27","author":"Zacher","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/neuonc\/nov289","article-title":"Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors","volume":"18","author":"Nikiforova","year":"2016","journal-title":"Neuro. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","article-title":"Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets","volume":"131","author":"Sahm","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_18","first-page":"179","article-title":"Retrospective Analysis of Molecular and Immunohistochemical characterization of 381 primary brain tumors","volume":"76","author":"Ballester","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.21037\/tlcr.2018.08.01","article-title":"A scalable solution for tumor mutational burden from formalinfixed, paraffin-embedded samples using the oncomine tumor mutation load assay","volume":"7","author":"Chaudhary","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/humu.22825","article-title":"Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing","volume":"36","author":"Samorodnitsky","year":"2015","journal-title":"Hum. Mutat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/neuonc\/nop075","article-title":"Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses","volume":"12","author":"Vogazianou","year":"2010","journal-title":"Neuro. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma","volume":"66","author":"Jenkins","year":"2006","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.jnen.0000235122.98052.8f","article-title":"Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss","volume":"65","author":"Griffin","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmoldx.2016.06.002","article-title":"Diagnostic detection of allelic losses and imbalances by next-generation sequencing: 1p\/19q co-deletion analysis of gliomas","volume":"18","author":"Dubbink","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Na, K., Kim, H.S., Shim, H.S., Chang, J.H., Kang, S.G., and Kim, S.H. (2019). Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: A single institutional experience of 135 cases. J. Neurooncol., 445\u2013454.","DOI":"10.1007\/s11060-019-03114-1"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12032-018-1119-2","article-title":"Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization","volume":"35","author":"Sim","year":"2018","journal-title":"Med. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jnen\/59.6.539","article-title":"Loss of heterozygosity on chromosome 19 in secondary glioblastomas","volume":"59","author":"Nakamura","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_28","unstructured":"Database of Single Nucleotide Polymorphisms (dbSNP) (2017, April 11). Bethesda (MD): National Center for Biotechnology Information, National Library of Medicine, Available online: http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"20761","DOI":"10.18632\/oncotarget.25099","article-title":"Clinical application of targeted next-generation sequencing for colorectal cancer patients: A multicentric Belgian experience","volume":"9","author":"Fontanges","year":"2018","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/0008-5472.CAN-17-0337","article-title":"Variant review with the integrative genomics viewer (IGV)","volume":"77","author":"Robinson","year":"2017","journal-title":"Can. Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/6\/773\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:56:06Z","timestamp":1760187366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/6\/773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["cancers11060773"],"URL":"https:\/\/doi.org\/10.3390\/cancers11060773","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]}}}